chrisvoncsefalvay/vaers-outcomes huggingface dataset:
has been so sick ever since; nasal & chest congestion; feeling weak; chest congestion; vomiting; fatigue; Yesterday a doctor said his lungs were clear but he has phlegm in the bronchial area & throat; This spontaneous case was reported by a nurse and describes the occurrence of MALAISE (has been so sick ever since), NASAL CONGESTION (nasal & chest congestion), ASTHENIA (feeling weak), PRODUCTIVE COUGH (Yesterday a doctor said his lungs were clear but he has phlegm in the bronchial area & throat) and CHEST DISCOMFORT (chest congestion) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Anaphylaxis, COVID-19 (Patient had COVID in August 2021 & recovered with a lot of problems.) in August 2021, COVID-19 pneumonia (Had double Covid pneumonia, was reported.), White blood cell count low, Platelet count low and Hospitalization. Previously administered products included for COVID-19 treatment: Monoclonal antibodies and Remdesivir. Past adverse reactions to the above products included No adverse event with Monoclonal antibodies and Remdesivir. Concurrent medical conditions included Drug allergy (Had anaphylaxis as a child to a sulfa drug, was reported.).    On 24-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Dec-2021, the patient experienced PRODUCTIVE COUGH (Yesterday a doctor said his lungs were clear but he has phlegm in the bronchial area & throat). On an unknown date, the patient experienced MALAISE (has been so sick ever since), NASAL CONGESTION (nasal & chest congestion), ASTHENIA (feeling weak), CHEST DISCOMFORT (chest congestion), VOMITING (vomiting) and FATIGUE (fatigue). At the time of the report, MALAISE (has been so sick ever since), NASAL CONGESTION (nasal & chest congestion), ASTHENIA (feeling weak), PRODUCTIVE COUGH (Yesterday a doctor said his lungs were clear but he has phlegm in the bronchial area & throat), CHEST DISCOMFORT (chest congestion), VOMITING (vomiting) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Oxygen saturation: 94-98 (normal) saturations go down to 94 then back up to 98.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.  Patient had COVID in Aug, 2021, his platelets and white blood count went down, was hospitalized for 8 days, got treatment and recovered.
Woke up morning after vaccination and "knew something was wrong, could not move body for 24 hours"
Information has been received from a physician concerning a 7-month-old male who in may 2007, was vaccinated PO with a 2mL forth dose of Rotateq. It was noted that the patient received the 3-dose series at 6 months old. No adverse reaction was noted. Unspecified medical attention was sought. No additional information was available at that time. There was no product quality complaint. Additional information has been requested.
Back of right arm where varicella was given began to itch- turn red.  By Monday area was side of a small dinner plate and had a area inside that was hard and was the size of a softball.  Advised to see a physician.  Seen by Dr.  Told an allergic reaction to the vaccine and it would get better on its own.  Talked to agency on 9/22/10 and it is no longer hot and is going down in size.
Left upper arm pain, swelling since 24 hours after shots. + Erythema - ROM of arm.
PATIENT DEVELOPED SIGNIFICANT AXILLARY LYMPHADENOPATHY ON LEFT SIDE (ON THE SAME SIDE THAT THE VACCINATION WAS ADMINISTERED). SYMPTOMS BEGAN ROUGHLY 24 HOURS AFTER VACCINATION, AND LASTED FOR 48 HOURS. PATIENT'S LYMPH NODES ARE STILL SWOLLEN, HOWEVER NOT NEARLY AS PAINFUL (4 DAYS AFTER VACCINATION). PATIENT SELF TREATED WITH TYLENOL AND IBUPROFEN, BUT THE PAIN WAS STILL SIGNIFICANT.
Narrative: Patient was admitted for a severe case of COVID-19 despite receiving both vaccines in the series on 01/28/2021 and 02/26/2021.
Fever to 104 started 7 days after measles vaccination that lasted for 48 hours.  During that illness she had one very brief jerking movement.  She started having another fever 2 weeks later during which she had approximately 15 jerking movements over the course of a couple hours lasting one second.  She is being worked up for myoclonic jerks.  Her older brother has had similar episodes that started during a fever 10 days after his MMR vaccination.
presents with altered mental status.  Her medical comorbidities include chronic kidney disease stage III, hypertension, depression, hyperlipidemia, and history of endometrial cancer status post hysterectomy in 2021.  was febrile at 38.1° C
Within 3 minutes of receiving the vaccination my Tongue began to tingle and then I began to lose felling in  it. This is normal to me consuming almonds. I took a Benadryl and it helped.
complaints of generalized weakness.  Patient states she was sitting at home when she developed sudden weakness throughout her body.  She states she walked to the bathroom and felt as though she was going to fall down.  She reports feeling sweaty as if she was having a hot flash.  She states her symptoms lasted approximately 45 minutes and resolved after arriving to the ER. She denies feeling dizzy, lightheaded, no visual disturbances, paresthesia or headache.  She denies any chest pain or shortness of breath.  No recent fever, cough or chills.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HBP" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Treatment was Paxlovid from 05Sep2023 to 10Sep2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 09-APR-2015, the patient was vaccinated with improperly stored PNEUMOVAX (lot # K024976 exp date 09-JUN-2016) (dose and route not reported). The temperature and time of excursion were 0.55 degrees C for 560 hours. The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
miserable with his second shot; didn''t feel good and he had a fever; didn''t feel good and he had a fever; occasional headache; had a full blown migraine and he hadn''t had one of those in 10 years; This is a spontaneous report from a contactable consumer (patient's wife) from Pfizer sponsored program. A male patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date in 2021 as dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. Reporter stated, her husband was miserable with his second shot. He didn't feel good and he had a fever. He was not complaining anymore about anything other than an occasional headache. He had a bad migraine/ severe migraine and didn't know if it was related but it was a full blown migraine and he had not had one of those in 10 years. All the events experienced on an unspecified date. He doesn't know if it was related to the COVID vaccine. He almost went to the hospital for it because he hadn't had one in years but that's about it with him. He has had other injections too and the military forced him to not only take the COVID vaccine but they also forced him to take the shingles vaccine and the flu shot on an unspecified dates. He has had a lot of injections in a short period of time and it could of been from those as well. Outcome of the events was unknown at the time of reporting.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Blurry vision, shortness of breath, large and itchy lump on my arm, and rash developed on my arm from my armpit down to the elbow.
Severe neck pain; Severe shoulder pain; Pain under the ampit at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NECK PAIN (Severe neck pain), ARTHRALGIA (Severe shoulder pain) and VACCINATION SITE PAIN (Pain under the ampit at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NECK PAIN (Severe neck pain), ARTHRALGIA (Severe shoulder pain) and VACCINATION SITE PAIN (Pain under the ampit at the injection site). The patient was treated with PARACETAMOL at an unspecified dose and frequency. At the time of the report, NECK PAIN (Severe neck pain), ARTHRALGIA (Severe shoulder pain) and VACCINATION SITE PAIN (Pain under the ampit at the injection site) outcome was unknown.            No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.
Sore throat, sore arm, swollen injection site, rash on face, very tired. The Gave benadryl for rash, Tylenol for soreness.
This case was reported by a physician via sales rep and described the occurrence of injection site cellulitis in a 17-year-old male patient who received Bexsero for prophylaxis. On 16th July 2018, the patient received Bexsero. On 16th July 2018, immediately after receiving Bexsero, the patient experienced injection site cellulitis and injection site pain. On an unknown date, the outcome of the injection site cellulitis and injection site pain were unknown. It was unknown if the reporter considered the injection site cellulitis and injection site pain to be related to Bexsero. Additional details were provided as follows: The patient received Bexsero on an unknown arm. The healthcare professional (HCP) reported that the patient was vaccinated with Bexsero and immediately had pain in arm at injection site. Three days later, the patient was diagnosed with cellulitis in the injected arm. The sales representative did not have any additional details to provide.
patient tested positive for covid 3 days after vaccination. Had fever, fatigue, and body aches.
Patient reported red, hard, swollen lump at injection site the day after administration. Also reported injection site to be hot and sore to touch. Symptoms still present as of 2/1/23 when reported.
After about 5 minutes of vaccine administration, patient complained of dizziness, light-headedness, hot and feverish (temperature taken with forehead contact-less thermometer read 97.2F),  tingling in extremities, and a metallic taste in mouth. Patient had to lay down on the floor to stop dizziness. Provided the patient with a cup of water. Symptoms lasted about 30 minutes. After that, patient stated she felt much better but had to stay sitting in our pharmacy for another 30 minutes. When asked if her throat was closing up, patient said no. When asked if we should call an ambulance, patient said no.
Patient received ZOSTAVAX on 9-10-10 the next day she got a small shingles rash.
Information has been received from a consumer on 09-Jun-2010. A female (initials and DOB unknown) received influenza virus vaccine polyvalent (manufacturer unknown) and experienced an unspecified reaction. The reporter felt the reaction was due to the vaccine containing eggs. Additional information is not expected. This case was originally report to Merck & Co., Inc. (manufacturer case # 1006USA01073). The company considered the event unassessable due to insufficient information. Information derived from this AE report does not change the current safety profile of the product.
Around 1200 today patient began to c/o body aches, wife took his temp and was 102. Advised if this goes on longer than 3 days and/or patient develops any breathing issues would go to urgent care and/or hopital. 4/26- F/u call no answer
Approximately four minutes after vaccination patient became pale and unresponsive. BP 90/60, HR 93, O2 Sat 93%. When she regained consciousness attempted to walk with nurses and parent short distance to stretcher. Lost consciousness again and was carried to stretcher. 911 called. Slowly regained consciousness. Sipped apple juice. Within 10 minutes, O2 Sat 97%. Evaluated by EMT-Ps, but was not transported to hospital. Walked out of clinic on own, feeling much better.
Information has been received from a healthcare worker (operations manager) referring to unknown number of patients. On unknown dates, the patients were administered improperly stored GARDASIL, lot # K005881, expiry date: 14-JAN-2017, (route, dose and frequency were not reported). This is one of several reports received from the same reporter. Additional information has been requested.
according to grandma upon arriving home temp was 99 about 15-30 mins later the t102; pt shook all over & turned blue; pt also blowing bubbles; pt had 2 more sz type exp p/that;
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date in 2015, the patient received the first dose of GARDASIL 9 (exact dose, route of administration, lot # and expiration date were not provided). On 15-APR-2016, the patient received the second dose of GARDASIL 9 lot # L038503, expiration date: 18-DEC-2017 (exact dose and route of administration were not provided) and on 02-AUG-2016, the third dose of GARDASIL 9 (exact dose, route of administration, lot # and expiration date were not provided). There were no adverse effects reported. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to an adult patient of an unknown age and gender who on 29-MAY-2015 was vaccinated with a dose of GARDASIL (lot # K006960) (expiration date, dose and route not reported) that was exposed to only one temperature excursion of 63 hours. No adverse effects had been observed or reported. This is one of several reports received from the same source. Additional information has been requested.
Patient was administered second dose of Pfizer vaccine. Post vaccine administration search of computer record revealed that first vaccine was administered on 06/10/2021. 21 days from 06/10/2021 is 07/01/2021. Second dose was administered on 06/23/2021.
Information has been received from a physician concerning a 5 year old patient who on an unknown date was vaccinated with the second dose of MMR II (Lot number not reported). About three months post vaccination, the patient presented with swelling on the jaw that looked like the mumps. The patient sought unspecified medical attention. Additional information has been requested.
Patient received second dose of Pfizer 02/13/22.  On 02/15/22 while shopping with her father, the patient was found," drooling, gradually losing tone becoming weak before she began to have jerking motions" per her father that lasted for 20 minutes. EMS was called to the scene and administered 4mg of Versed IM which lead to improvement of involuntary movement.  Patient was admitted to Hospital were she is currently being seen by Neurology for new onset of seizures. All possible attributing factors for new onset of seizures are being  ruled out.
Stiff arm after shot for several days. Sharp headaches off and on for a week. Took ibuprofen for pain.
fever started MN 18NOV92; arm swelled up red big (arm bled alot @ inject); fever got as high as 106 during noc & did not go down until 19NOV92; started vomiting 18NOV92; seen by MD 18NOV92; dx allergic reaction to DTP & prescribed Pediapro;
Modern a vaccine administered 03/05/2021. Tinnitus onset the week of 03/14/2021. Has not diminished or become less significant since that time.
Large swollen area resembling hive and itching.  Fever and really tired and weak.
Uncontrollable shakes began at 10:30pm that evening. Took about 1.5 hours and seven layers of blankets before it would stop.  Restlessness and chills continued throughout the night. At 1:30am I finally took OTC flu/cold liquid medicine. (NyQuil) and then continued DayQuil and NyQuil for the next 48 hours.  Fever began and continued until end of day the following day. Although not as serve once fever reducer was being taken. (24 hours) Body aches that night and continuing into the next day. (24 hours) Headache began the next day and continued for almost 48 hours post injection.  Fatigue that night and continued for two days post injection (48 hours) All around would categorize day one after the inject as "flu-like" although this was a bit worse than when I've had the flu. Day 2 post injection was more "cold-like" but higher fatigue than I'm used to.  I normally never get headaches, and I had a dull headache for the two days post injection.
Patient complains of pain on R arm. Site of complaint is not at site of injection so not sure if it an injection site reaction. Patient reported event on 3/19/18 on 5th day since receiving vaccination. The area is red and warm to the touch.
patient received his second dose  of shingrix on 12/12/20 . He reported today that the following day after he received the vaccine, he experienced  intense itch and chicken pox like spots all over his chest. he has tried anti itching cream without resolution . Pharmacist recommended patient go to his primary doctor to get prescription for antiviral cream/tab for symptoms relief. Will follow up with patient later today.
09/02/2022 - Patient reports a temperature of 101, nausea, muscle aches, HA, large red veins in eyes and shooting head pain
States developed upper redness swelling/pain R upper extremity evening of 1/22/10. To ED on 1/24/10. See attached discharge instructions. Received 2 vaccines in R extremity.
pts mother stated his mouth became numb like he went to the dentist.  He became jittery, had stomach pain with a 102 temp.  A couple of weeks later he developed a sore throat that was a lump on the inside of his throat.  He saw his doctor in October.  He had blood work and was tested for thyroid disease that was negative so now will have to have a US that is scheduled for tomorrow.  Pt still has stomach pain.
He is not able to stand up; 2 months ago the symptoms started; Patient can't walk and has to use a walker; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Feb-2022 and was forwarded to Moderna on 15-Feb-2022.    This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (He is not able to stand up) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 044821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (allergic to amoxicillin) and Blood pressure management.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In December 2021, the patient experienced GAIT INABILITY (Patient can't walk and has to use a walker). On an unknown date, the patient experienced DYSSTASIA (He is not able to stand up) (seriousness criterion disability) and VACCINATION COMPLICATION (2 months ago the symptoms started). At the time of the report, DYSSTASIA (He is not able to stand up), GAIT INABILITY (Patient can't walk and has to use a walker) and VACCINATION COMPLICATION (2 months ago the symptoms started) had not resolved.            He was taking other concomitant medications besides blood pressure.  Patient received both Moderna Covid-19 vaccines in his deltoid muscle.He didn't tested positive for Covid-19 and did not received any other vaccine within 1 month prior to Moderna Covid-19 vaccine. He doesn't had any acute or chronic illnesses.He didn't experienced any similar event on the past. The symptomsare ongoing and no treatment was applied.  Company Comment: This case refers to a 62-year-old male patient with no relevant reported medical history who experienced the unexpected event of Dysstasia on an unspecified date after a dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 is not affected by this report. Event seriousness assessed as per Regulatory Authority reporting.   Most recent FOLLOW-UP information incorporated above includes: On 15-Feb-2022: Significant follow up appended. New events was added and date of 2nd dose was updated, add 1st dose details were updated; Sender's Comments: This case refers to a 62-year-old male patient with no relevant reported medical history who experienced the unexpected event of Dysstasia on an unspecified date after a dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 is not affected by this report. Event seriousness assessed as per Regulatory Authority reporting.
Skin rash/large red blotches on lower half of body.  Itching occurred 6-7 hours after vaccines given.  Parents administered Benadryl syrup by mouth.
Cold like symptoms, Fever, chills, aches  for 12 hours, went into  chest congestion  with a cough that took a month to go away. Got better and then had rebound covid three days later that had milder symptoms.  Mucinex was very helpful for cough and congestion, Tylenol
Pt. went home and told her grandmother she got the shot from nurse and the lady across from her gave her the nasal. Dad called the office and I spoke with him about this. He says she explained everything to him like she got it and had a funny taste in her mouth.
Swelling of face. Patient stated she just took some Benadryl and went away over time.